Cargando...
Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis
BACKGROUND: Programmed cell death-ligand 1 (PD-L1) may be a useful molecule for targeted immunotherapy. Therefore, this meta-analysis aimed to investigate PD-L1 expression in breast cancer and its associations with clinicopathological factors and outcomes, which may help determine whether PD-L1 expr...
Guardado en:
| Publicado en: | BMC Cancer |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5645886/ https://ncbi.nlm.nih.gov/pubmed/29041905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3670-1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|